Global SNP Genotyping and Analysis Market to Reach $53.1 Billion by 2030
The global market for SNP Genotyping and Analysis estimated at US$13.4 Billion in the year 2022, is projected to reach a revised size of US$53.1 Billion by 2030, growing at a CAGR of 18.8% over the analysis period 2022-2030. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is projected to record 22.3% CAGR and reach US$20.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Taqman Allelic Discrimination segment is readjusted to a revised 18.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 18.1% CAGR
The SNP Genotyping and Analysis market in the U.S. is estimated at US$4.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9 Billion by the year 2030 trailing a CAGR of 18.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.9% and 15.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.Select Competitors (Total 42 Featured) -
- Affymetrix, Inc.
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- Illumina, Inc.
- Life Technologies Corporation
- Sequenom, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- SNP Genotyping and Analysis - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for SNP Genotyping and Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for SNP Genotyping and Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for SNP Genotyping by Microarrays and GeneChips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for SNP Genotyping by Microarrays and GeneChips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for SNP Genotyping by Microarrays and GeneChips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Taqman Allelic Discrimination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Taqman Allelic Discrimination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Taqman Allelic Discrimination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for SNP Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for SNP Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for SNP Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Applied Biosciences SNPlex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Applied Biosciences SNPlex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Applied Biosciences SNPlex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Sequenom MassARRAY MALDI-TOF by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Sequenom MassARRAY MALDI-TOF by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Sequenom MassARRAY MALDI-TOF by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Diagnostic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Diagnostic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Diagnostic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Pharmaceuticals and Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World Historic Review for Pharmaceuticals and Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 24: World 16-Year Perspective for Pharmaceuticals and Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 25: World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 26: World Historic Review for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 27: World 16-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 28: World Recent Past, Current & Future Analysis for Breeding and Animal Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 29: World Historic Review for Breeding and Animal Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 30: World 16-Year Perspective for Breeding and Animal Livestock by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 31: World SNP Genotyping and Analysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 32: USA Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: USA Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 34: USA 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 35: USA Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: USA Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 37: USA 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Canada Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: Canada 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 41: Canada Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Canada Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: Canada 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- JAPAN
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Japan Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: Japan 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 47: Japan Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: Japan Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: Japan 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- CHINA
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 50: China Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: China Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: China 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 53: China Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: China Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: China 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- EUROPE
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 56: Europe Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 57: Europe Historic Review for SNP Genotyping and Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: Europe 16-Year Perspective for SNP Genotyping and Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 59: Europe Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: Europe Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: Europe 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 62: Europe Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Europe Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 64: Europe 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- FRANCE
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 65: France Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: France Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 67: France 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 68: France Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: France Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 70: France 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- GERMANY
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 71: Germany Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: Germany Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 73: Germany 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 74: Germany Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Germany Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 76: Germany 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- ITALY
- Table 77: Italy Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: Italy Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 79: Italy 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 80: Italy Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Italy Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 82: Italy 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- UNITED KINGDOM
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 83: UK Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: UK Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 85: UK 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 86: UK Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: UK Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 88: UK 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- REST OF EUROPE
- Table 89: Rest of Europe Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: Rest of Europe Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 91: Rest of Europe 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of Europe Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 94: Rest of Europe 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- ASIA-PACIFIC
- SNP Genotyping and Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 95: Asia-Pacific Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Asia-Pacific Historic Review for SNP Genotyping and Analysis by Technology - SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 97: Asia-Pacific 16-Year Perspective for SNP Genotyping and Analysis by Technology - Percentage Breakdown of Value Sales for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2014, 2023 & 2030
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for SNP Genotyping and Analysis by Application - Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 100: Asia-Pacific 16-Year Perspective for SNP Genotyping and Analysis by Application - Percentage Breakdown of Value Sales for Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology and Breeding and Animal Livestock for the Years 2014, 2023 & 2030
- REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affymetrix, Inc.
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- Illumina, Inc.
- Life Technologies Corporation
- Sequenom, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 173 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 13.4 Billion |
| Forecasted Market Value ( USD | $ 53.1 Billion |
| Compound Annual Growth Rate | 18.8% |
| Regions Covered | Global |
